Changes to care delivery at nine international pediatric diabetes clinics in response to the COVID ‐19 global pandemic
Authors:
- Angelica Cristello SarteauASAngelica Cristello Sarteau
- Katherine Janine SourisKSKatherine Janine Souris
- Jessica WangJWJessica Wang
- Ananta AddalaAAAnanta Addala
- Sarah CorathersSCSarah Corathers
- Gun ForsanderGFGun Forsander
- Bruce KingBKBruce King
- Jennifer R. LawJLJennifer R. Law
- Wei LiuWLWei Liu
- Faisal MalikFMFaisal Malik
Open Access
- 19 January 2021
- journal article
- research article
- Published by Wiley in Pediatric Diabetes
- Vol. 22 (3) , 463-468
Abstract
Background Pediatric diabetes clinics around the world rapidly adapted care in response to COVID‐19. We explored provider perceptions of care delivery adaptations and challenges for providers and patients across nine international pediatric diabetes clinics. Methods Providers in a quality improvement collaborative completed a questionnaire about clinic adaptations, including roles, care delivery methods, and provider and patient concerns and challenges. We employed a rapid analysis to identify main themes. Results Providers described adaptations within multiple domains of care delivery, including provider roles and workload, clinical encounter and team meeting format, care delivery platforms, self‐management technology education, and patient‐provider data sharing. Providers reported concerns about potential negative impacts on patients from COVID‐19 and the clinical adaptations it required, including fears related to telemedicine efficacy, blood glucose and insulin pump/pen data sharing, and delayed care‐seeking. Particular concern was expressed about already vulnerable patients. Simultaneously, providers reported 'silver linings' of adaptations that they perceived as having potential to inform care and self‐management recommendations going forward, including time‐saving clinic processes, telemedicine, lifestyle changes compelled by COVID‐19, and improvements to family and clinic staff literacy around data sharing. Conclusions Providers across diverse clinical settings reported care delivery adaptations in response to COVID‐19—particularly telemedicine processes—created challenges and opportunities to improve care quality and patient health. To develop quality care during COVID‐19, providers emphasized the importance of generating evidence about which in‐person or telemedicine processes were most beneficial for specific care scenarios, and incorporating the unique care needs of the most vulnerable patients.Keywords
This publication has 11 references indexed in Scilit:
- The Effectiveness of Virtual Training on the MiniMed™ 670G System in People with Type 1 Diabetes During the COVID-19 PandemicDiabetes Technology & Therapeutics, 2021
- Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID‐19 pandemicDiabetic Medicine, 2020
- Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?Diabetes Care, 2020
- Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetesDiabetes Research and Clinical Practice, 2020
- Unintended Consequences of Coronavirus Disease-2019: Remember General PediatricsThe Journal of Pediatrics, 2020
- COVID ‐19 outbreak and pediatric diabetes: Perceptions of health care professionals worldwidePediatric Diabetes, 2020
- Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical ActivityDiabetes Technology & Therapeutics, 2020
- Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health AdministrationImplementation Science, 2019
- Can rapid approaches to qualitative analysis deliver timely, valid findings to clinical leaders? A mixed methods study comparing rapid and thematic analysisBMJ Open, 2018
- Your Exclusion, My Inclusion: Reflections on a Career Working With the Most Challenging and Vulnerable in DiabetesDiabetes Spectrum, 2018